Nucletron introduces brachytherapy treatment planning system

Nucletron, a radiotherapy cancer treatment company, has introduced its Oncentra Brachy, a volume-based treatment planning system to optimize cancer treatment planning with brachytherapy.

Oncentra Brachy, a fully DICOM-compatible treatment planning system, features optimization algorithms to ensure efficient treatment, according to the Veenendaal, Netherlands-based company. The new system provides 3D contouring and margining tools to identify regions of interest on CT or in a multi-modality imaging environment using image registration for CT, MR and PET data.

The company said its Oncentra Brachy allows clinicians to create treatment plans, ranging from simple to complex, in user-defined workspaces that allow for adaptation to specific clinical workflows. Real-time information-sharing provides immediate access for the entire medical team and facilitates the exchange of treatment plans remotely with decentralized planning capabilities, Nucletron said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.